Montenegro
Diabetes country report 2011 — 2050
Number of adults (20–79 years) with diabetes in Montenegro (ME)
2011 | 41.9 thousand |
2024 | 57.8 thousand |
2050 | 60.5 thousand |
Montenegro is one of the 60 countries and territories in the IDF Europe Region. Montenegro has the second highest diabetes prevalence (20-79 years) in the Region.
Data source(s) used for the diabetes estimates in adults:
- Estimates extrapolated from Bulgaria, Cyprus, Greece, North Macedonia, Romania, Slovenia and Turkey.
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 41.9 | 57.8 | 60.5 |
Age-standardised prevalence of diabetes, % | - | 7.7 | 10.7 | 12.3 |
Proportion of people with undiagnosed diabetes, % | - | - | 33.5 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 19.4 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 41.5 | 40.8 |
Age-standardised prevalence of IFG, % | - | - | 8.5 | 9.0 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 48.9 | 35.6 | 33.7 |
Age-standardised prevalence of IGT, % | - | 9.7 | 7.5 | 7.6 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 506.0 | 383.2 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 9.3 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | - | - |
Total diabetes-related health expenditure, ID million | - | - | - | - |
Diabetes-related health expenditure per person, USD | - | - | - | - |
Diabetes-related health expenditure per person, ID | - | - | - | - |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 1,663.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 321.1 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 455.1 | 454.1 | 425.6 |
Population of children and adolescents (0-19 y) | - | - | 155,211.5 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |